All Stories

  1. Repetitive Transcranial Magnetic Stimulation Combined with Antidepressants for the First Episode of Major Depressive Disorder

    Article • Current Neuropharmacology, October 2020, Bentham Science Publishers

    Narong Maneeton

  2. Associated factors for depressive disorder in patients with end-stage renal disease treated with continuous ambulatory peritoneal dialysis

    Article • Therapeutics and Clinical Risk Management, April 2019, Dove Medical Press

    Narong Maneeton

  3. Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis

    Article • November 2018, Dove Medical Press

    Narong Maneeton, Professor Manit Srisurapanont

  4. Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review

    Article • August 2018, Dove Medical Press

    Dr Vudhichai - Boonyanaruthee, Professor Manit Srisurapanont, Narong Maneeton

  5. Risperidone for children and adolescents with autism spectrum disorder: a systematic review

    Article • July 2018, Dove Medical Press

    Narong Maneeton, Professor Manit Srisurapanont

  6. Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study

    Article • April 2018, Dove Medical Press

    Narong Maneeton

  7. Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis

    Article • April 2017, Dove Medical Press

    Narong Maneeton, Professor Manit Srisurapanont

  8. Delirium after a traumatic brain injury: predictors and symptom patterns

    Article • February 2017, Dove Medical Press

    Narong Maneeton, Professor Manit Srisurapanont

  9. Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study

    Article • January 2017, Dove Medical Press

    Narong Maneeton

  10. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials

    Article • Drug Design Development and Therapy, January 2016, Dove Medical Press

    Narong Maneeton, Dr Vudhichai - Boonyanaruthee, Professor Manit Srisurapanont

  11. Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized controlled trials

    Article • November 2015, Dove Medical Press

    Narong Maneeton, Professor Manit Srisurapanont

  12. Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials

    Article • Drug Design Development and Therapy, April 2015, Taylor & Francis

    Narong Maneeton, Professor Manit Srisurapanont

  13. Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD

    Article • Drug Design Development and Therapy, October 2014, Taylor & Francis

    Narong Maneeton, Professor Manit Srisurapanont

  14. A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder

    Article • August 2014, Dove Medical Press

    Narong Maneeton

  15. Prevalence and relationship between major depressive disorder and lung cancer: a cross-sectional study

    Article • OncoTargets and Therapy, May 2014, Dove Medical Press

    Narong Maneeton

  16. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized–controlled trials comparison with venlafaxine

    Article • Drug Design Development and Therapy, September 2013, Taylor & Francis

    Narong Maneeton, Professor Manit Srisurapanont

  17. Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial

    Article • Drug Design Development and Therapy, July 2013, Taylor & Francis

    Kaweesak Chittawatanarat, Narong Maneeton, Professor Manit Srisurapanont

  18. Prevalence and predictors of depression in patients with systemic lupus erythematosus: a cross-sectional study

    Article • Neuropsychiatric Disease and Treatment, June 2013, Taylor & Francis

    Narong Maneeton